NFKB1 and amyotrophic lateral sclerosis: Aberrant activation of NF-κB signaling in ALS-afflicted skeletal muscles is a key driver of chronic inflammation, suppression of myogenic regulatory factors, and upregulation of proteolytic enzymes, collectively contributing to muscle degeneration and wasting [6,8,23,24,25,26].